0

Back to ASCP Scientific Updates: Molecular Marker Testing Recommendations for Lung Cancer Treatment
ASCP Scientific Updates: Molecular Marker Testing Recommendations for Lung Cancer Treatment

ASCP Scientific Updates: Molecular Marker Testing Recommendations for Lung Cancer Treatment

ASCP Scientific Updates are a quarterly series of 30-minute on-demand webcasts containing up-to-the-minute information on various therapeutic agents, disease states, and thresholds that impact immuno-oncology diagnostics in solid tumors and hematologic malignancies.

This webcast addresses the latest molecular marker testing recommendations for lung cancer treatment and is designed to educate pathologists and laboratory personnel on the sensitive assays and new technologies involved in lung cancer testing. Starting with a general overall view of the current state of molecular testing in lung cancer, you will learn about the exciting and evolving role of next generation sequencing (NGS) and circulating cfDNA (liquid biopsy) in lung cancer testing, the limitations in small biopsies, the significant role of immunohistochemistry (IHC) for single-gene assessments, and understand the guidelines that will lead to more uniform testing in a clinically reliable way across the laboratory profession. 

The activity offers 0.5 CME, CMLE, or SAMs CME credit.

  • List Price: $0.00 USD

Item Details:

ASCP Scientific Updates are a quarterly series of 30-minute on-demand webcasts containing up-to-the-minute information on various therapeutic agents, disease states, and thresholds that impact immuno-oncology diagnostics in solid tumors and hematologic malignancies.

This webcast addresses the...

Back to ASCP Scientific Updates: Molecular Marker Testing Recommendations for Lung Cancer Treatment
View More

Bought This Bought That ...